Lipitor, Atorvastatin
Lipitor, Atorvastatin Newswire (Page 5)

Lipitor, Atorvastatin Newswire (Page 5)

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic). (Page 5)

Results 81 - 100 of 826 in Lipitor, Atorvastatin (generic)

  1. The Opposite of Sex, Drugs, and Rock & Roll: Deborah's StoryRead the original story w/Photo

    May 6, 2015 | Psychology Today

    I'm delighted to welcome Elizabeth Saenger, my colleague at the Center for Environmental Therapeutics , for a new twist to our Chronotherapy blog. Elizabeth is a Harvard-educated psychologist who helps people help themselves live the way they want to, often with style and originality.


  2. Move for cheap drugsRead the original story

    May 6, 2015 | Yahoo!

    Some of the most commonly prescribed big-name drugs for cholesterol, depression and reflux will be up to $18.85 per script cheaper under a Federal Budget attack on medicine prices. _The West Australian _ can reveal that Health Minister Sussan Ley has included Australia's two biggest-selling prescription drugs - cholesterol-lowering atorvastatin and rosuvastatin, sold as Lipitor and Crestor - on a Federal Government hit list aimed at saving up to $2 billion over five years.


  3. Generics substitution, bioequivalence standards, and oversight of...Read the original story w/Photo

    May 4, 2015 | AEI

    The rules underlying the assessment of quality of generic drugs, and their bioequivalence to brand name products, have not changed significantly since the passage of the Hatch-Waxman Act in 1984. Yet the products on the market are significantly more complicated today, which may imply that two bioequivalent products are not identical to each other.


  4. 'Zombie' Bacteria May Help Heal WoundsRead the original story w/Photo

    May 4, 2015 | How Stuff Works

    There's a very good chance that some of the medicine in your home contains an animal-derived ingredient. The most frequently included animal-based ingredients in meds, according to a new study in the British Medical Journal, are lactose , gelatin and magnesium stearate, which can also come from a cow and is a magnesium salt containing stearic acid.


  5. Viagra Keeps Pfizer's China Sales RisingRead the original story w/Photo

    May 3, 2015 | Bloomberg

    Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Chinese men have long used traditional medicines such as deer antler, caterpillar fungus, and wolfberry to treat impotence.


  6. Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia ratsRead the original story

    May 1, 2015 | Lipids in Health and Disease

    Background Asymmetric Dimethylarginine is an inhibitor of endogenous nitric oxide synthase, which is the key synthase for nitric oxide production. Whether statins could protect endothelium by reducing ADMA concentration is unclear, and whether this effect is associated with the dose of statins usage is also needed further studied.


  7. To Your Good Health:Read the original story w/Photo

    May 1, 2015 | TwinCities

    Q. The senior center in my community is kept at a temperature that many of us seniors find too cool for our comfort. After two hours of playing Scrabble or watching a film, we feel chilled to the bone.


  8. Pfizer's strategic response to the threat of generic competition upheld by the Federal CourtRead the original story w/Photo

    Apr 30, 2015 | JD Supra

    On 25 February 2015, the Federal Court handed down its much-anticipated judgment in the matter of ACCC v Pfizer Australia Pty Ltd. In dismissing the Australian Competition and Consumer Commission's allegations, Justice Flick held that Pfizer neither misused its market power, nor engaged in exclusive dealing, in relation to its supply of atorvastatin to pharmacies in Australia. The ACCC has since lodged a Notice of Appeal, publicly stating that the Commission "seeks clarity from the Full Court on issues of market power and anti-competitive purpose."


  9. Will Pfizer (NYSE: PFE) Break in Two?Read the original story w/Photo

    Apr 30, 2015 | Learn Bonds

    Pfizer reported first quarter profit of $0.51 per share on $10.86 billion of revenue Tuesday -beating estimates of $0.49 per share. The performance was largely driven by strong demand for its vaccine and cancer drugs.


  10. Big pharma deals: Mylan, Teva push on despite rejectionsRead the original story w/Photo

    Apr 30, 2015 | PhysOrg Weblog

    Suitors in the generic drug industry's big consolidation push signaled Wednesday they would keep fighting for deals, even after Perrigo rejected a sweetened offer from Mylan. It was the second time in less than a week that Mylan raised its bid, this time to $35.6 billion, to merge the two into a company with $15 billion in annual sales.


  11. Federal Court Overseeing Hundreds of Lipitor Lawsuits Denies Defense...Read the original story w/Photo

    Apr 29, 2015 | PRWeb

    Bernstein Liebhard LLP is representing Lipitor lawsuit plaintiffs in the federal multidistrict litigation, which involves thousands of cases alleging the statin medication increases a patient's risk for new-onset Type 2 diabetes. Our Firm is representing Lipitor lawsuit plaintiffs in this proceeding, and we are pleased that discovery is continuing to progress.


  12. Pfizer Profit Tops Estimates as Prevnar Vaccine Gets More UsersRead the original story

    Apr 28, 2015 | The Washington Post

    Pfizer Inc. reported first-quarter profit that exceeded analysts' estimates, boosted by better-than- projected sales of its Prevnar vaccines. Earnings of 51 cents a share topped the average projection of 50 cents, according to data compiled by Bloomberg.


  13. Dow 30 Earnings: Pfizer First Quarter 2015Read the original story

    Apr 28, 2015 | Value Line

    Pfizer , the New York-based drugmaker and a Dow-30 component, has reported first-quarter earnings of $0.38 a share, versus $0.36 in the comparable period of 2014. As has been the case in recent quarters, year-over-year improvement was driven by effective cost controls, offset by lower revenues.


  14. Pfizer Profit Tops Estimates as Prevnar Vaccine Sales RiseRead the original story

    Apr 28, 2015 | The Washington Post

    Earnings of 51 cents a share topped the average projection of 50 cents, according to data compiled by Bloomberg. First- quarter sales of $10.9 billion, compared with analysts' projections of $10.8 billion.


  15. Pfizer Earnings Preview: 5 Things You Need to KnowRead the original story w/Photo

    Apr 28, 2015 | Investopedia

    Pfizer may not be the growth giant it was when it was riding cholesterol-fighting drug Lipitor's coattails to success, but it nonetheless remains a critical gauge of success in the pharmaceutical industry that Wall Street and investors closely monitor. Pfizer is slated to report its first-quarter earnings results on Tuesday, April 28, and investors will be looking for revenue stabilization in the wake of patent losses, cost reductions to temper a drop in sales, and positive commentary regarding the company's pipeline.


  16. Federal Lipitor Lawsuits Progress, as New Status Report Details...Read the original story w/Photo

    Apr 24, 2015 | PRWeb

    Bernstein Liebhard LLP is representing Lipitor lawsuit plaintiffs in the federal multidistrict litigation who allege that Pfizer, Inc. failed to adequately warn patients that use of the statin medication could increase their risk for Type 2 diabetes. These two bellwether trials may provide important insight into how juries will react to evidence put forth in similar lawsuits involving Lipitor and diabetes.


  17. Prescription drug prices are a hard pill to swallowRead the original story w/Photo

    Apr 24, 2015 | KBCI CBS 2

    To help you keep more of your money in your pocket, consumer reports had its shoppers check out prices at almost 200 pharmacies. You'd think that the price of a drug would be fairly standard.


  18. A pilot study of ezetimibe vs. atorvastatin for improving...Read the original story

    Apr 23, 2015 | Lipids in Health and Disease

    Department of Cardiovascular Medicine, Faculty of Life Sciences, Graduate School of Medical Science, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 862-8556, Japan Division of Preventive Cardiology, Department of Cardiovascular Medicine, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto 862-8556, Japan Background Elevated cholesterol in type 2 diabetes mellitus can cause endothelial dysfunction. An effective clinical therapy to improve endothelial dysfunction remains to be established.


  19. Drug companies using doctors, discount cards to skirt generic substitutionsRead the original story w/Photo

    Apr 22, 2015 | CBC News

    At his family medicine clinic in downtown Toronto , Dr. Nav Persaud refuses to hand out the drug coupon cards. It's a sales promotion that's happening right in the doctor's office.


  20. Amgen enjoys 51% spike in Q1 profitRead the original story w/Photo

    Apr 22, 2015 | The China Post

    Amgen Inc. boosted its first-quarter profit by 51 percent, thanks to surging drug sales and ongoing cost cuts designed to free up cash for an unprecedented burst of new product launches. Meanwhile, it has assembled a new sales group to market its first drug in the growing cardiovascular market, just-approved chronic heart failure treatment Corlanor.